Arcus Biosciences Funding & Investors
Hayward, CA
Arcus Biosciences, Inc. operates as a biotechnology company. The Company discovers, develops, and commercializes immunotherapies for the treatment of cancer patients. Arcus Biosciences serves customers in the United States.
arcusbio.comTotal Amount Raised: $1,117,049,984
Arcus Biosciences Funding Rounds
Post Ipo Debt
$150,000,000
Post Ipo Debt Investors
Hercules CapitalPost Ipo Equity
$320,000,000
Post Ipo Equity Investors
Gilead SciencesPost Ipo Equity
$220,350,000
Post Ipo Equity Investors
Gilead SciencesPost Ipo Equity
$200,000,000
Post Ipo Equity Investors
Gilead SciencesIPO
Unknown
Series C
$107,000,000
Series C Investors
GVEcoR1 CapitalWellington ManagementHillhouse InvestmentInvus GroupForesite CapitalLeerink SwannCelgeneTaiho VenturesAisling CapitalDroia VenturesDecheng CapitalBiotechnology Value FundColumn GroupSeries B
$70,000,000
Series B Investors
GVInvus GroupDroia VenturesStanford UniversityColumn GroupForesite CapitalNovartisCelgeneTaiho VenturesRTA CapitalSeries A
$49,700,000
Series A Investors
CelgeneColumn Group
Funding info provided by Diffbot.